Circular RNA FAT atypical cadherin 1 (circFAT1)/microRNA-525-5p/spindle and kinetochore-associated complex subunit 1 (SKA1) axis regulates oxaliplatin resistance in breast cancer by activating the notch and Wnt signaling pathway

References

• Anderson BO, et al. Early detection of breast cancer in countries with limited resources. Breast J. 2003;9(Suppl s2):S51–9.
   PubMedGoogle Scholar
• DeSantis C, et al. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64(1):52–62.
   PubMed Web of Science ®Google Scholar
• Garufi C, et al. Single-agent oxaliplatin in pretreated advanced breast cancer patients: a phase II study. Ann Oncol. 2001;12(2):179–182.
   PubMed Web of Science ®Google Scholar
• Garutti M, et al. Platinum salts in patients with breast cancer: a focus on predictive factors. Int J Mol Sci. 2019;20(14):14.
   Web of Science ®Google Scholar
• Raymond E, et al. Cellular and molecular pharmacology of oxaliplatin. Mol Cancer Ther. 2002;1(3):227–235.
   PubMed Web of Science ®Google Scholar
• Lim S, et al. Inhibition of Chk1 by miR-320c increases oxaliplatin responsiveness in triple-negative breast cancer. Oncogenesis. 2020;9(10):91.
   PubMed Web of Science ®Google Scholar
• Kulcheski FR, Christoff AP, Margis R. Circular RNAs are miRNA sponges and can be used as a new class of biomarker. J Biotechnol. 2016;238:42–51.
   PubMed Web of Science ®Google Scholar
• Zhao B, Song X, Guan H. CircACAP2 promotes breast cancer proliferation and metastasis by targeting miR-29a/b-3p-COL5A1 axis. Life Sci. 2020;244:117179.
   PubMed Web of Science ®Google Scholar
• Zeng K, et al. CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7. Cell Death Dis. 2018;9(4):417.
   PubMed Web of Science ®Google Scholar
• Su Y, et al. CircRNA Cdr1as functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression. Aging (Albany NY). 2019;11(19):8183–8203.
   PubMedGoogle Scholar
• Liu G, et al. Circ_0006528 contributes to paclitaxel resistance of breast cancer cells by regulating miR-1299/CDK8 Axis. Onco Targets Ther. 2020;13:9497–9511.
   PubMed Web of Science ®Google Scholar
• Hu K, et al. Exosomes mediated transfer of circ_UBE2D2 enhances the resistance of breast cancer to tamoxifen by binding to miR-200a-3p. Med Sci Monit. 2020;26:e922253.
   PubMed Web of Science ®Google Scholar
• Zang H, et al. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p. Thorac Cancer. 2020;11(7):1891–1903.
   PubMed Web of Science ®Google Scholar
• Liu G, et al. CircFAT1 sponges miR-375 to promote the expression of Yes-associated protein 1 in osteosarcoma cells. Mol Cancer. 2018;17(1):170.
   PubMed Web of Science ®Google Scholar
• Hu B, et al. CircFAT1 Suppresses Colorectal Cancer Development Through Regulating miR-520b/UHRF1 Axis or miR-302c-3p/UHRF1 Axis. Cancer Biother Radiopharm. 2021;36(1):45–57.
   PubMed Web of Science ®Google Scholar
• Wei H, et al. CircFAT1 promotes hepatocellular carcinoma progression via miR-30a-5p/REEP3 pathway. J Cell Mol Med. 2020;24(24):14561–14570.
   PubMed Web of Science ®Google Scholar
• Zhang W, et al. Downregulation of Circ_0071589 suppresses cisplatin resistance in colorectal cancer by Regulating the MiR-526b-3p/KLF12 Axis. Cancer Manag Res. 2021;13:2717–2731.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Han B, et al. Down-regulation of lncRNA DNAJC3-AS1 inhibits colon cancer via regulating miR-214-3p/LIVIN axis. Bioengineered. 2020;11(1):524–535.
   PubMed Web of Science ®Google Scholar
• Zhang L, et al. LncRNA CASC11 promoted gastric cancer cell proliferation, migration and invasion in vitro by regulating cell cycle pathway. Cell Cycle. 2018;17(15):1886–1900.
   PubMed Web of Science ®Google Scholar
• Yang Z, et al. Long intergenic noncoding RNA00265 promotes proliferation of gastric cancer via the microRNA-144-3p/Chromobox 4 axis. Bioengineered. 2021;12(1):1012–1025.
   Google Scholar
• Wang X, et al. SKA1 promotes malignant phenotype and progression of glioma via multiple signaling pathways. Cancer Cell Int. 2019;19(1):324.
   PubMed Web of Science ®Google Scholar
• Hortobagyi GN. Treatment of breast cancer. N Engl J Med. 1998;339(14):974–984.
   PubMed Web of Science ®Google Scholar
• Ji X, et al. Chemoresistance mechanisms of breast cancer and their countermeasures. Biomed Pharmacother. 2019;114:108800.
   PubMed Web of Science ®Google Scholar
• Yong W, et al. Hsa_circ_0071589 promotes carcinogenesis via the miR-600/EZH2 axis in colorectal cancer. Biomed Pharmacother. 2018;102:1188–1194.
   PubMed Web of Science ®Google Scholar
• Yang W, et al. Circ-ABCB10 contributes to paclitaxel resistance in breast cancer through Let-7a-5p/DUSP7 Axis. Cancer Manag Res. 2020;12:2327–2337.
   PubMed Web of Science ®Google Scholar
• Dou D, et al. CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis. Cancer Cell Int. 2020;20(1):454.
   PubMed Web of Science ®Google Scholar
• Liang Y, et al. circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer. Oncogene. 2019;38(42):6850–6866.
   PubMed Web of Science ®Google Scholar
• Chen M, Liu LX. MiR-525-5p repressed metastasis and anoikis resistance in cervical cancer via blocking UBE2C/ZEB1/2 Signal Axis. Dig Dis Sci. 2020;65(8):2442–2451.
   PubMed Web of Science ®Google Scholar
• Wang L, et al. Role of lncRNAHCP5/microRNA-525-5p/PRC1 crosstalk in the malignant behaviors of ovarian cancer cells. Exp Cell Res. 2020;394(1):112129.
   PubMed Web of Science ®Google Scholar
• Yang Z, et al. Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation. Cancer Lett. 2020;473:118–129.
   PubMed Web of Science ®Google Scholar
• Tian F, et al. Downregulation of SKA1 gene expression inhibits cell growth in human bladder cancer. Cancer Biother Radiopharm. 2015;30(7):271–277.
   PubMed Web of Science ®Google Scholar
• Xiao J, Yu H, Ma Z. LINC00339 promotes growth and invasiveness of hepatocellular carcinoma by the miR-1182/SKA1 pathway. Onco Targets Ther. 2019;12:4481–4488.
   PubMed Web of Science ®Google Scholar
• Hu D, et al. SKA1 overexpression is associated with the prognosis of esophageal squamous cell carcinoma and regulates cell proliferation and migration. Int J Mol Med. 2019;44(5):1971–1978.
   PubMed Web of Science ®Google Scholar
• Shen L, et al. SKA1 regulates the metastasis and cisplatin resistance of non-small cell lung cancer. Oncol Rep. 2016;35(5):2561–2568.
   PubMed Web of Science ®Google Scholar
• Chen Z, et al. RCC2 promotes breast cancer progression through regulation of Wnt signaling and inducing EMT. J Cancer. 2019;10(27):6837–6847.
   PubMed Web of Science ®Google Scholar
• Xia S, et al. Oridonin inhibits breast cancer growth and metastasis through blocking the Notch signaling. Saudi Pharm J. 2017;25(4):638–643.
   PubMed Web of Science ®Google Scholar
• Yan Y, et al. HIF-2alpha promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways. J Exp Clin Cancer Res. 2018;37(1):256.
   PubMed Web of Science ®Google Scholar